Education
About Us
Working with TipRanks
Follow Us
CVS Health Corp (CVS)
NYSE:CVS
CVS Stock Chart & Stats
Day’s Range― - ―
52-Week Range$43.56 - $71.66
Previous CloseN/A
Volume5.40M
Average Volume (3M)9.99M
Market Cap
$87.75B
Enterprise Value$128.61B
Total Cash (Recent Filing)$10.08B
Total Debt (Recent Filing)$81.21B
Price to Earnings (P/E)19.0
Beta0.64
Next Earnings
May 01, 2025EPS Estimate
1.65Last Dividend Ex-Date
Apr 22, 2025Dividend Yield3.83%
Share Statistics
EPS (TTM)1.19
Shares Outstanding1,262,383,800
10 Day Avg. Volume13,182,140
30 Day Avg. Volume9,992,622
Financial Highlights & Ratios
PEG RatioN/A
Price to Book (P/B)N/A
Price to Sales (P/S)0.23
Price to Cash Flow (P/CF)11.40
P/FCF Ratio9.00
Enterprise Value/Market Cap1.47
Enterprise Value/RevenueN/A
Enterprise Value/Gross Profit2.50
Enterprise Value/Ebitda9.43
Forecast
1Y Price Target
$77.20Price Target Upside14.44% Upside
Rating ConsensusStrong Buy
Number of Analyst Covering20
---
Bulls Say, Bears Say
Bulls Say
EarningsCVS' profit in the Healthcare Benefit segment was better than expected due in part to the rationalization of members in 2025.
Financial GuidanceCVS expects financial results will meet or exceed previously issued guidance for the full year 2025.
Margin ExpansionExecution at Aetna, stabilizing reimbursement pressure from the rollout of CostVantage, and Cordavis product launches could support further margin upside over time.
Bears Say
Operational ChallengesThere are still some moving pieces like elevated utilization and challenges with Oak Street/Signify.
Regulatory RisksHeadline risk could arise around PBM reform/legislation seeking to break up PBM ownership of pharmacies.
---
Ownership Overview
1.02% Insiders
31.70% Mutual Funds
0.78% Other Institutional Investors
46.14% Public Companies and
Individual Investors
CVS FAQ
What was CVS Health Corp’s price range in the past 12 months?
CVS Health Corp lowest stock price was $43.56 and its highest was $71.66 in the past 12 months.
What is CVS Health Corp’s market cap?
CVS Health Corp’s market cap is $87.75B.
When is CVS Health Corp’s upcoming earnings report date?
CVS Health Corp’s upcoming earnings report date is May 01, 2025 which is 3 days ago.
How were CVS Health Corp’s earnings last quarter?
CVS Health Corp released its earnings results on May 01, 2025. The company reported $2.25 earnings per share for the quarter, beating the consensus estimate of $1.703 by $0.547.
Is CVS Health Corp overvalued?
According to Wall Street analysts CVS Health Corp’s price is currently Undervalued.
Does CVS Health Corp pay dividends?
CVS Health Corp pays a Quarterly dividend of $0.665 which represents an annual dividend yield of 3.83%. See more information on CVS Health Corp dividends here
What is CVS Health Corp’s EPS estimate?
CVS Health Corp’s EPS estimate is 1.65.
How many shares outstanding does CVS Health Corp have?
CVS Health Corp has 1,262,383,800 shares outstanding.
What happened to CVS Health Corp’s price movement after its last earnings report?
CVS Health Corp reported an EPS of $2.25 in its last earnings report, beating expectations of $1.703. Following the earnings report the stock price went up 4.107%.
Which hedge fund is a major shareholder of CVS Health Corp?
Currently, no hedge funds are holding shares in CVS
---
CVS Health Stock Smart Score
Outperform
1
2
3
4
5
6
7
8
9
10
Analyst Consensus
Strong Buy
Average Price Target:
$77.20 (14.44% Upside)
$77.20 (14.44% Upside)
Blogger Sentiment
Bullish
CVS Sentiment 74%
Sector Average 71%
Sector Average 71%
Hedge Fund Trend
Increased
By 25.4M Shares
Last Quarter.
Last Quarter.
Insider Transactions
Bought Shares
Worth $1.5M over
the Last 3 Months
the Last 3 Months
Crowd Wisdom
Positive
Last 7 Days ▲ 0.3%
Last 30 Days ▲ 3.4%
Last 30 Days ▲ 3.4%
News Sentiment
Very Bullish
Bullish news 100%
Bearish news 0%
Bearish news 0%
Technicals
SMA
Positive
20 days / 200 days
Momentum
4.21%
12-Months-Change
Fundamentals
Return on Equity
6.07%
Trailing 12-Months
Asset Growth
1.20%
Trailing 12-Months
Company Description
CVS Health Corp
CVS Health Corporation provides health services in the United States. The company's Health Care Benefits segment offers traditional, voluntary, and consumer-directed health insurance products and related services. It serves employer groups, individuals, college students, part-time and hourly workers, health plans, health care providers, governmental units, government-sponsored plans, labor groups, and expatriates. Its Pharmacy Services segment offers pharmacy benefit management solutions, including plan design and administration, formulary management, retail pharmacy network management, mail order pharmacy, specialty pharmacy and infusion, clinical, and disease and medical spend management services. It serves employers, insurance companies, unions, government employee groups, health plans, prescription drug plans, Medicaid managed care plans, plans offered on public health insurance and private health insurance exchanges, other sponsors of health benefit plans, and individuals. This segment operates retail specialty pharmacy stores; and specialty mail-order, mail-order dispensing, and compounding pharmacies, as well as branches for infusion and enteral nutrition services. The company's Retail/LTC segment sells prescription and over-the-counter drugs, consumer health and beauty products, and personal care products; and provides health care services through its MinuteClinic walk-in medical clinics. This segment also distributes prescription drugs; and provides related pharmacy consulting and other ancillary services to care facilities and other care settings. As of December 31, 2021, it operated approximately 9,900 retail locations and 1,200 MinuteClinic locations, as well as online retail pharmacy websites, LTC pharmacies, and onsite pharmacies. The company was formerly known as CVS Caremark Corporation and changed its name to CVS Health Corporation in September 2014. CVS Health Corporation was founded in 1963 and is headquartered in Woonsocket, Rhode Island.
---
CVS Company Deck
---
CVS Earnings Call
Q1 2025
0:00 / 0:00
Earnings Call Sentiment|Neutral
CVS Health delivered strong financial results in Q1 2025 and increased its full-year EPS guidance, reflecting solid performance across all segments. The company is leading in market innovation with expanded access to GLP-1 medications and growth in pharmacy market share. However, challenges persist in individual exchange products, legislative impacts in Arkansas, and elevated medical cost trends. The overall sentiment is cautiously optimistic with strong highlights, but significant lowlights remain.Read More>---
CVS Revenue Breakdown
46.57% Health Services
35.05% Health Care Benefits
33.40% Pharmacy & Consumer Wellness
0.12% Corporate/ Other
---
CVS Stock 12 Month Forecast
Average Price Target
$77.20
▲(14.44% Upside)
Technical Analysis
---